Nearly one in ten unsure if they have Long Covid

Almost 5% have the condition and socially disadvantaged groups are most affected

2025-03-18

(Press-News.org) UNDER EMBARGO UNTIL 00:01 AM UK TIME ON TUESDAY 18 MARCH 2025

Almost one in ten people (9.1%) in England think they could have Long Covid but aren’t sure, according to a new analysis of NHS England survey data by the University of Southampton.

Researchers also found that 4.8% of people reported having Long Covid, with higher rates among people living in deprived areas, people with particular ethnic backgrounds, parents or carers, and those with another long-term condition.

The findings are published today [18 March] in the journal Health Expectations.

Professor Nisreen A Alwan, who has pioneered research into Long Covid since 2020 and who co-authored the study, said: “This analysis adds further evidence of the unfairness of Long Covid, with people who are already disadvantaged in society more likely to be affected.

“It also shows us that many people aren’t sure if they have it, and may need diagnosis, treatment and support.

“Long Covid is still a very significant issue impacting individuals, families, the economy and wider society. We need to do more to prevent it, diagnose it, and properly support people who are affected by it.”

Long Covid is a chronic condition induced by COVID-19 infection that can have a significant impact on people’s daily lives. Symptoms include fatigue, feeling short of breath, ‘brain fog’, and heart palpitations, amongst many others.

University of Southampton researchers analysed over 750,000 responses to the GP Patient Survey (England) 2023 to explore the prevalence of Long Covid, and the factors associated with both having the condition and being uncertain of having it.

They found that people aged under 25yrs, males, people from particular ethnic minorities, and people without long-term conditions were more likely to be unsure if they had Long Covid.

Men are generally less likely to seek medical advice than women, which could partly explain their higher level of uncertainty. The team also say stigma and self-doubt could discourage people from seeking a diagnosis.

Mirembe Woodrow, who is studying for a PhD at Southampton and who carried out the analysis, said: “We were really surprised to find so many people weren’t sure whether they had Long Covid or not, and the study shows there is still work to do to increase awareness of the condition and remove barriers to accessing diagnosis, treatment and support.

“We don’t want Long Covid to be another factor that contributes to the widening health gap in the UK.”

The most recent data from the 2024 GP Patient Survey indicates Long Covid prevalence and uncertainty are not declining (5.0% and 9.0%). Professor Alwan’s team intends to carry out further work using the survey to understand what could be driving inequality in prevalence, impact and support for Long Covid.

Exploring Long Covid prevalence and patient uncertainty by sociodemographic characteristics using GP Patient Survey data is published in Health Expectations and is available online.

Ends

Contact

Steve Williams, Media Manager, University of Southampton, press@soton.ac.uk or 023 8059 3212.

Notes for editors

Exploring Long Covid prevalence and patient uncertainty by sociodemographic characteristics using GP Patient Survey data is published in Health Expectations. An advanced copy of the paper is available upon request. For Interviews with Professor Nisreen A Alwan please contact Steve Williams, Media Manager, University of Southampton press@soton.ac.uk or 023 8059 3212. Additional information

The University of Southampton drives original thinking, turns knowledge into action and impact, and creates solutions to the world’s challenges. We are among the top 100 institutions globally (QS World University Rankings 2025). Our academics are leaders in their fields, forging links with high-profile international businesses and organisations, and inspiring a 22,000-strong community of exceptional students, from over 135 countries worldwide. Through our high-quality education, the University helps students on a journey of discovery to realise their potential and join our global network of over 200,000 alumni. www.southampton.ac.uk

www.southampton.ac.uk/news/contact-press-team.page

Follow us on X: https://twitter.com/UoSMedia

END

ELSE PRESS RELEASES FROM THIS DATE:

Scientists unlock new dimension in light manipulation, ushering a new era in photonic technology

2025-03-18

Researchers at Heriot-Watt University have made a ground-breaking discovery paving the way for a transformative era in photonic technology. For decades, scientists have theorised the possibility of manipulating the optical properties of light by adding a new dimension—time. This once-elusive concept has now become a reality thanks to nanophotonics experts from the School of Engineering and Physical Sciences in Edinburgh, Scotland. The team’s breakthrough emerged from experiments with nanomaterials known as transparent conducting oxides (TCOs) - a special ...

Current antivirals likely less effective against severe infection caused by bird flu virus in cows’ milk

2025-03-17

(MEMPHIS, Tenn. – March 17, 2025) As the H5N1 avian influenza outbreak continues, scientists are working to better understand the virus’s threat to human health. The virus has been found in dairy cows’ milk and has infected farm workers, prompting scientists at St. Jude Children’s Research Hospital to study potential treatments. Results showed that in a preclinical model, two FDA–approved flu antivirals generally did not successfully treat severe H5N1 infections. Additionally, the researchers found that the route of infection, whether through ...

Lassa fever vaccine enters phase 1 clinical trial

2025-03-17

Thomas Jefferson University has initiated a phase 1 clinical trial for a Lassa virus (LASV) vaccine developed at Jefferson in collaboration with the University of Maryland, Baltimore (UMB), at the Center of Vaccine Development and Global Health, UMB. Currently, there are no approved vaccines against the Lassa virus. The clinical study is a dose-ranging study that will assess the safety and immunogenicity of the candidate vaccine for both the rabies virus and LASV. The experimental vaccine is based on an attenuated and killed rabies virus vaccine similar to current rabies vaccines and has an additional ...

Institute for Healthcare Improvement Honors Hebrew SeniorLife’s Orchard Cove and NewBridge on the Charles

2025-03-17

Outpatient primary care clinics at Hebrew SeniorLife’s Orchard Cove and NewBridge on the Charles communities have been recognized by the Institute for Healthcare Improvement (IHI) as Age-Friendly Health Systems — Committed to Care Excellence. “I want to express my gratitude to the team at Hebrew SeniorLife for your dedication to age-friendly care,” said Leslie Pelton, MPA, Vice President, Institute for Healthcare Improvement (IHI). “Age-Friendly Health Systems and IHI celebrate your recognition as an Age-Friendly ...

Dialing in the temperature needed for precise nuclear timekeeping

2025-03-17

For decades, atomic clocks have been the pinnacle of precision timekeeping, enabling GPS navigation, cutting-edge physics research, and tests of fundamental theories. But researchers at JILA, led by JILA and NIST Fellow and University of Colorado Boulder physics professor Jun Ye, in collaboration with the Technical University of Vienna, are pushing beyond atomic transitions to something potentially even more stable: a nuclear clock. This clock could revolutionize timekeeping by using a uniquely low-energy transition within the nucleus of a thorium-229 atom. This transition is less sensitive to environmental disturbances than modern atomic clocks and has been proposed for tests of fundamental ...

Fewer than half of Medicaid managed care plans provide all FDA-approved medications for alcohol use disorder

2025-03-17

FOR IMMEDIATE RELEASE Monday, March 17, 2025 Contact: Jillian McKoy, jpmckoy@bu.edu Michael Saunders, msaunder@bu.edu ## As health complications and deaths from alcohol use disorder (AUD) increase in the United States, it is critical that people who could benefit from medications have access to the drugs that the US Food and Drug Administration has approved to treat AUD. Yet, for individuals who have alcohol use disorder and are covered by Medicaid, accessing these medications is difficult; past research indicates that only about 1 in 20 Medicaid enrollees with alcohol use disorder receive these ...

Mount Sinai researchers specific therapy that teaches patients to tolerate stomach and body discomfort improved functional brain deficits linked to visceral disgust that can cause of food avoidance in

2025-03-17

Mount Sinai Researchers Find Specific Therapy That Teaches Patients to Tolerate Stomach and Body Discomfort Improved Functional Brain Deficits Linked to Visceral Disgust That Can Cause Food Avoidance in Adolescent Females with Anorexia Nervosa and other Low-Weight Eating Disorders Corresponding Author: Kurt P. Schulz, PhD, Associate Professor, Center of Excellence in Eating and Weight Disorders, Icahn School of Medicine at Mount Sinai, New York, and other co-authors Bottom Line: A trial of interoceptive exposure - a therapy that teaches patients how to tolerate stomach and body discomfort in order to reduce restrictive eating - improved functional deficits in a brain region ...

New ACP guideline recommends combination therapy for acute episodic migraines

2025-03-17

Follow @Annalsofim on X, Facebook, Instagram, threads, and Linkedin Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf ...

Last supper of 15-million-year-old freshwater fish

2025-03-17

18th March 2025, Sydney: In an Australian first, a team of scientists led by Australian Museum and UNSW Sydney palaeontologist, Dr Matthew McCurry, have described a new species of 15-million-year-old fossilised freshwater fish, Ferruaspis brocksi, that shows preserved stomach contents as well as the pattern of colouration. The research is published today in The Journal of Vertebrate Palaeontology (DOI - 10.1080/02724634.2024.2445684) Named after Professor Jochen J. Brocks from the Australian National University, who discovered several of the fossilised species at the Australian Museum’s, McGraths Flat fossil site near Gulgong, NSW, Ferruaspis brocksi is the first ...

Slow, silent ‘scream’ of epithelial cells detected for first time

2025-03-17

EMBARGOED UNTIL 3/17/2025, 3:00PM ET March 17, 2025 Slow, Silent ‘Scream’ of Epithelial Cells Detected for First Time Team from UMass Amherst uncovers communication by “electric spiking” in cells once thought to be mute, which could enable bioelectric applications AMHERST, Mass. — It has long been thought that only nerve and heart cells use electric impulses to communicate, while epithelial cells — which compose the linings of our skin, organs ...

Mount Sinai researchers specific therapy that teaches patients to tolerate stomach and body discomfort improved functional brain deficits linked to visceral disgust that can cause of food avoidance in

Nearly one in ten unsure if they have Long Covid

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: